Skip to main content
Equibles

MORGAN STANLEY

Position in INKT — MiNK Therapeutics, Inc.

CIK 895421 NEW YORK, NY
Back to INKT Full portfolio

Position in INKT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,320
+$225 QoQ
Shares Held
113
+8.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 27 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in INKT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. INKT ranks #465 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in INKT

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,320 113
2026-03-31 $1,095 104
2025-12-31 $1,159 104
2025-09-30 $1,610 115
2025-06-30 $162 22
2025-03-31 $206 24
2024-12-31 $230 334
2024-09-30 $250 336
2024-06-30 $360 383
2024-03-31 $542 600
2023-12-31 $4,798 4,487
2023-09-30 $8,904 8,097
2023-06-30 $25,590 12,187
2022-12-31 $107 41
2022-09-30 $88 42
2022-06-30 $652 463
2022-03-31 $202 90
2021-12-31 $189,862 42,570